Acta Scientific Cancer Biology (ISSN: 2582-4473)

Editorial Volume 10 Issue 4

Treatment of Neuroendocrine Tumor

Kunal Joon* and M R Mozafari

NIIMS, Greater Noida, India.

*Corresponding Author: Kunal Joon, NIIMS, Greater Noida, India.

Received: May 15, 2026 Published: June 10, 2026

Abstract

These cancer starts at neuroendocrine cells gene responsible for them p55 and MEN 1, MEN 2 gene, RET gene and most common organs of occurrence is liver, lung, Pancreas, intestine and rectum. These are which releases hormones and cure is repair through stem cell therapy and gene therapy.
Keywords: Gene Therapy; Stem Cell Therapy; DNA Architecture Theory; Gene Editing

References

  1. Mayo Clinic. “Neuroendocrine tumors”.
  2. Cleveland Clinic. “Neuroendocrine tumors”.
  3. Cancer Research UK. “Neuroendocrine cancer”.
  4. Qamar Sultana., et al. “A comprehensive review on neuroendocrine neoplasms: presentation, pathophysiology and management”. Journal of Clinical Medicine 15 (2023): 5138.

Citation

Citation: Kunal Joon and M R Mozafari. “Treatment of Neuroendocrine Tumor". Acta Scientific Cancer Biology 10.4 (2026): 01-02.

Copyright

Copyright: © 2026 Kunal Joon and M R Mozafari. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Publication Certificate
    Authors will be provided with the Publication Certificate after their successful publication
  • Last Date for submission
    Authors are requested to submit manuscripts on/before June 18, 2026, for the upcoming issue of 2026.

Contact US